A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Clinical trial NCT02587806 · UNKNOWN
Trial details
- NCT number
- NCT02587806
- Sponsor
- Novo Cellular Medicine Institute LLP
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-02-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.